I am primarily interested in improving the treatment of malaria by antimalarial drugs and factors affecting the outcome. Furthermore, much emphasis of my research is on the use of molecular markers as tools to monitor and possibly hinder emergence and spread of drug resistance in the malaria endemic world.

Current research
Research in antimalarial drugs is currently based on testing:
The efficiency of antimalarial drugs in treatment of various patient groups
The availability and quality of antimalarial drugs in the malaria endemic world
The molecular mapping of antimalarial drug resistance by genotyping malaria parasites from various malaria endemic areas

Furthermore, current research is as well by involvement in general studies of malaria epidemiology and trends of decreasing malaria in selected African countries.